Please login to the form below

Not currently logged in

FDA sets 10 December date for Pfizer’s COVID-19 vaccine meeting

FDA newIndependent experts will discuss EUA submission for mRNA-based vaccine

AZ’s COVID-19 vaccine demonstrates efficacy rate of up to 90%

AZ NEWAcross two dosing regimens, vaccine has average efficacy of 70%

Lilly links up with Precision BioSciences in genome editing deal

Eli Lilly new HQPrecision will receive an upfront cash payment of $100m

UK could approve Pfizer’s COVID-19 vaccine this week

Coronavirus vaccineThe Telegraph reported the possible timeframe on Sunday

Caroline Gosling

Q&A: Caroline Gosling

PME interviews Rubica's Director of Culture & Engagement

Isabel Gibson

Q&A: Isabel Gibson

PME interviews W2O ISO's Managing Director

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

Is creativity in quarantine?

Chris Ross explores the value of creativity – and how to realise it

PME Nov 2020

Novartis and smartpatient launch app experience for wet AMD patients

Wet AMD is the leading cause of severe vision loss and legal blindness in people over the age of 65

MyTherapy app

OPEN Health names Rob Barker chief executive officer

Barker succeeds outgoing OPEN Health CEO and co-founder David Rowley

Rob Barker

Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm

Perlmutter is set to join the board of AI drug discovery biotech Insitro

Roger Perlmutter

COVID-19 Updates and Daily News

Featured jobs


Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...
New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....